Virtus Health (VRT.AX) Stock Price
Virtus Health Price
Over the last 12 years Virtus Health grew revenue by 13.8% annually, reaching 324.60 M AUD. Earnings per share have grown at 20.3% per year over the last 12 years. For Virtus Health, the net margin of 13.3% is up versus 11.0% a few years ago. The payout ratio is around 64% of earnings.
Virtus Health stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Virtus Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Virtus Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Virtus Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Virtus Health Price |
|---|
Virtus Health Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Virtus Health Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM AUD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM AUD |
| EBITM AUD |
| EBIT MARGIN% |
| NET INCOMEM AUD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.AUD |
| SHARESM |
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022e | 2023e | 2024e | 2025e | 2026e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 132.00 | 165.00 | 186.00 | 201.00 | 234.00 | 261.00 | 256.00 | 263.00 | 280.00 | 258.00 | 324.00 | 335.00 | 355.00 | 379.00 | 400.00 | 425.00 |
| 12.82 | 25.00 | 12.73 | 8.06 | 16.42 | 11.54 | -1.92 | 2.73 | 6.46 | -7.86 | 25.58 | 3.40 | 5.97 | 6.76 | 5.54 | 6.25 |
| 74.24 | 72.73 | 70.43 | 73.13 | 72.65 | 71.26 | 72.27 | 73.00 | 72.50 | 72.87 | 72.53 | 72.53 | 72.53 | 72.53 | 72.53 | 72.53 |
| 98.00 | 120.00 | 131.00 | 147.00 | 170.00 | 186.00 | 185.00 | 192.00 | 203.00 | 188.00 | 235.00 | 242.98 | 257.48 | 274.89 | 290.12 | 308.26 |
| 31.00 | 38.00 | 39.00 | 51.00 | 49.00 | 53.00 | 47.00 | 50.00 | 46.00 | 30.00 | 57.00 | 51.00 | 61.00 | 69.00 | 79.00 | 92.00 |
| 23.48 | 23.03 | 20.97 | 25.37 | 20.94 | 20.31 | 18.36 | 19.01 | 16.43 | 11.63 | 17.59 | 15.22 | 17.18 | 18.21 | 19.75 | 21.65 |
| 15.00 | 19.00 | 10.00 | 30.00 | 29.00 | 32.00 | 28.00 | 30.00 | 28.00 | – | 43.00 | 29.00 | 35.00 | 41.00 | 48.00 | 58.00 |
| -1,600.00 | 26.67 | -47.37 | 200.00 | -3.33 | 10.34 | -12.50 | 7.14 | -6.67 | – | – | -32.56 | 20.69 | 17.14 | 17.07 | 20.83 |
| – | – | – | – | – | – | – | – | – | – | – | 0.17 | – | – | – | – |
| 53.60 | 58.20 | 63.40 | 80.70 | 80.93 | 80.88 | 81.04 | 81.22 | 81.62 | 80.08 | 81.22 | 81.22 | 81.22 | 81.22 | 81.22 | 81.22 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Virtus Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Virtus Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Virtus Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Virtus Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Virtus Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Virtus Health stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Virtus Health Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Virtus Health business model & stock analysis
Virtus Health SWOT Analysis
Strengths
Virtus Health Ltd exhibits several strengths that contribute to its competitive position in the market. Firstly, the company benefits from a strong reputation and brand image, which enhances customer trust and loyalty. This is crucial in an industry where personalized and reliable healthcare solutions are sought after.
Secondly, Virtus Health has a well-established network of fertility clinics and healthcare professionals, allowing it to offer comprehensive fertility treatments and services. The company's experienced team of specialists and cutting-edge technologies contribute to its high success rates in assisted reproductive processes.
Furthermore, Virtus Health has a solid financial foundation, enabling the company to invest in research and development, expand its operations, and keep up with advancements in reproductive medicine. This financial stability also provides resilience in times of economic uncertainty.
Weaknesses
Despite its strengths, Virtus Health faces certain weaknesses that pose challenges to its growth. One notable weakness is the company's dependence on the regulatory environment. Changes in government policies or regulations related to reproductive medicine could impact Virtus Health's operations, potentially leading to increased costs or limitations on certain treatments.
Additionally, Virtus Health operates in a highly competitive market, with numerous other fertility clinics and healthcare providers. This intensifies competition and puts pressure on pricing and profitability. To maintain its market share, Virtus Health needs to continuously differentiate itself through innovation, quality, and service excellence.
Opportunities
Virtus Health can capitalize on several opportunities to further enhance its business. The growing demand for fertility treatments and assisted reproductive services presents a significant opportunity for market expansion. With increasing awareness and acceptance of such treatments globally, Virtus Health can tap into new markets and reach a larger customer base.
Furthermore, advancements in reproductive technologies and genetic testing offer potential growth avenues for Virtus Health. By adopting and integrating these technologies into its services, the company can stay at the forefront of innovation and provide more comprehensive and personalized solutions to its customers.
Threats
Virtus Health confronts several threats that pose risks to its business. One major threat is the potential for stricter regulations or legal challenges surrounding the ethical aspects of reproductive medicine. This could lead to increased scrutiny, limitations on certain procedures, or reputational damage for Virtus Health.
Moreover, changes in consumer preferences and trends could affect the demand for fertility treatments. For instance, societal shifts towards delaying parenthood or alternative family building options may impact the traditional market for reproductive services. Virtus Health needs to continually adapt and cater to evolving customer needs and preferences.
Virtus Health Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Virtus Health historical P/E ratio, EBIT multiple, and P/S ratio
Virtus Health annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Virtus Health shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Virtus Health Dividend History
9 years of dividend payments · 2 consecutive increases
Virtus Health dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Virtus Health Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 2/20/2023 | 0.25AUD | -AUD | 2023 Q2 |
| 8/21/2022 | 0.20AUD | -AUD | 2022 Q4 |
| 2/22/2022 | 0.23AUD | -AUD | 2022 Q2 |
| 8/23/2021 | 0.11AUD | 142.10 MAUD | 2021 Q4 |
| 2/16/2021 | 0.22AUD | 167.47 MAUD | 2021 Q2 |
| 8/18/2020 | 0.10AUD | -AUD | 2020 Q4 |
| 2/18/2020 | 0.17AUD | -AUD | 2020 Q2 |
Virtus Health shareholder structure
| % | Name |
|---|---|
101.51128% | |
9.14998% | |
5.36970% | |
5.07420% | |
4.33773% | |
3.54514% |
Virtus Health Executives and Management Board
Ms. Kate Munnings
Group Chief Executive Officer, Managing Director, Executive Director · since 2020
Mr. Richard Banks
Chief Strategy Officer, European Managing Director
Mr. Lyndon Hale
Executive Director · since 2021
Ms. Sonia Petering
Non-Executive Independent Chairman of the Board
Mr. Greg Couttas
Non-Executive Independent Director
Virtus Health Supply Chain
Virtus Health Supply Chain
Correlation: how closely stock prices move together
| # | Name | 1M | 3M | 6M | 1Y | 2Y | Trend |
|---|---|---|---|---|---|---|---|
| 1 | 0.59 | 0.14 | -0.16 | -0.23 | 0.76 | ||
| 2 | 0.30 | -0.28 | -0.30 | -0.28 | 0.69 | ||
| 3 | -0.07 | -0.30 | -0.84 | -0.78 | 0.33 |
| # | Name | 1M | 3M | 6M | 1Y | 2Y | Trend |
|---|---|---|---|---|---|---|---|
| 1 | Ceridin HCM Hldg Rg | -0.04 | -0.39 | -0.88 | -0.84 | -0.17 |
Frequently asked questions about Virtus Health
Virtus Health Ltd operates with an innovative business model in the reproductive healthcare industry. As a leading provider of fertility services, Virtus Health offers a comprehensive range of assisted reproductive technology (ART) solutions. The company conducts fertility assessments, consultations, and diagnostics, providing individuals and couples with personalized treatment plans to optimize their chances of starting a family. With a network of fertility clinics and laboratories, Virtus Health offers services like in vitro fertilization (IVF), egg freezing, donor programs, and preimplantation genetic testing. The company's business model focuses on delivering high-quality fertility care, promoting patient-centric approaches, and leveraging cutting-edge ART techniques to support individuals and families on their unique fertility journeys.
Virtus Health stock
Virtus Health Peer Group
Virtus Health Ticker
Virtus Health FIGI
All fundamentals and in-depth analysis of Virtus Health
Our stock analysis for Virtus Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Virtus Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.